Seres Health, Inc. announced the addition of Mark Wilcox, M.D., of the University of Leeds, to its Scientific Advisory Board (SAB). Professor Wilcox is Head of Microbiology and Academic Lead of Pathology at the Leeds Teaching Hospitals, Professor of Medical Microbiology at the University of Leeds, and is the Lead on Clostridium difficile for Public Health England. He is Chair of PHE's Rapid Review Panel, Deputy Chair of the UK Department of Health's Antimicrobial Resistance and Healthcare Associated Infection Committee and is a member of the PHE's Programme Board on Healthcare Associated Infection & Antimicrobial Resistance.

Prof. Wilcox is also an advisor to the European Centre for Disease Control. He has provided clinical advice as part of the FDA/EMA submissions for the approval of several novel antimicrobial agents.